|Day Low/High||56.18 / 56.50|
|52 Wk Low/High||38.41 / 57.73|
Unilever is voluntarily recalling a limited number of boxes of Ben & Jerry's Chocolate Fudge Brownie Pint Slices, which may inadvertently contain Vanilla Peanut Butter Cup Pint Slices.
Morgan Stanley leads the banks, while Kirkland & Ellis tops the law firms.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer breaks down the day's trending stocks on our daily Facebook Live show, which airs weekdays at 10 a.m. EST.
TheStreet's Action Alerts PLUS Portfolio manager Jim Cramer thinks Unilever is still a buy.
Cramer breaks down Thursday's trending stocks.
Unilever announced today that it has signed an agreement to acquire Sir Kensington's, a New York-based condiment maker.
Britain's exit from the European Union will have many casualties, but this international purveyor of beloved consumer brands should be just fine.
We are impressed by the way management has responded to controversial content concerns and we would not be one to bet against them moving forward.
The central bank will probably hike rates this week, which could have unpleasant consequences for bulls.
Siemens, Nestle and Toyota are just some of the top dividend paying stocks from outside the U.S. investors should be thinking about.
Is this small-cap biotech play the best way to profit from the growing worldwide demand for vaccines?
Despite Kraft Heinz-Unilever misfire, there are still promising candidates on the menu.
If you are already long the space, you likely need some protection at this point.
Unilever is one of the biggest consumer goods manufacturers in the world.
We want to be disciplined in our approach and take some Kraft Heinz off the table.
The fast food chain will sell to Restaurant Brands , which is backed by 3G and Berkshire Hathaway, for $1.8 billion.
A deal such as this could signal a market top.
Wall Street can't quite make up its mind on the consumer products giant facing forex and valuation challenges.
The world's biggest consumer goods company warns that a difficult environment lies ahead.
Johnson & Johnson is buying the Swiss biotech Actelion for $30 billion.
The Fed's words can cause just as much volatility in the markets as the president's.
Will President Donald Trump disappoint, as he more or less did in his press conference last week?